Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progestin and metformin in endometrial hyperplasia
IRCT20251216068350N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydroxyprogesterone caproate and metformin in Endometrial Hyperplasia Without Atypia (EH), sponsored by Kashan University of Medical Sciences. Started Mar 2026; status: completed.
02
Drugs
hydroxyprogesterone caproatemetformin
03
Conditions
Endometrial Hyperplasia Without Atypia (EH)
Beyond the preview
Go deeper on IRCT20251216068350N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251216068350N1.